In a victory for public health and reproductive rights advocates, the U.S. Food and Drug Administration has approved new labeling for the most widely used abortion drug, mifepristone. The labeling change says women can use the drug further into a pregnancy, with fewer visits to a doctor and at a lower dosage. The change replaces restrictions that the medical establishment had long considered outdated and deals a blow to states where anti-choice advocates had been trying to use the outdated FDA label to place restrictions on women’s use of the drug.